Sugammadex sodium

$0.00 1kg

Min. Order1kg
Purity99%
Cas No343306-79-6
Supply Ability1T
Update time2026-01-19

Shandong Hanjiang Chemical Co., Ltd

VIP3Y

China

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	Sugammadex sodium
CAS No	343306-79-6
EC-No
Min. Order	1kg
Purity	99%
Supply Ability	1T
Release date	2026/01/19

Product Name:	Sugammadex sodium
Synonyms:	ORG-25969/SugaMMadex;Sugammadex Na;ORG;Sugammadex IMP;Sugammadex soidum 343306-79-6;Sugammadex sodium iMpurity;6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-Carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-γ-cyclodextrin Sodium Salt;Sugammadex Sodium salt
CAS:	343306-79-6
MF:	C72H104Na8O48S8
MW:	2177.97
EINECS:	200-838-9
Product Categories:	API;343306-79-6
Mol File:	343306-79-6.mol

Sugammadex sodium Chemical Properties

storage temp.	Inert atmosphere,Room Temperature
solubility	DMF: 2.5 mg/ml; DMSO: 2.5 mg/ml; DMSO:PBS (pH 7.2) (1:30): 0.03 mg/ml
form	A crystalline solid
color	White to off-white
Water Solubility	H2O: 2mg/mL, clear
InChIKey	NIOBYNJFPSIMJF-OBHNVPISNA-N

Safety Information

MSDS Information

Sugammadex sodium Usage And Synthesis

Description	To facilitate tracheal intubation, mechanical ventilation, and surgical access, NMB agents are frequently used as non-anesthetic adjuncts in surgical procedures. Sugammadex is able to function as a pharmacologic sink of rocuronium and vecuronium, another non-depolarizing neuromuscular blocker, without the cardiovascular adverse effects experienced with reversal agents that directly interact with the cholinergic system. The γ-cyclodextrin has been designed to enhance binding of the guest by incorporating acidic side chains to promote an electrostatic interaction with the positive nitrogen of the blocker. Starting with γ-cyclodextrin, these side chains are readily installed by first halogenating with iodine or bromine to provide a handle for nucleophilic displacement with either 3-mercaptopropionic acid in the presence of sodium hydride or with 3-mercaptopropionic acid methyl ester and cesium carbonate. The latter requires hydrolysis with sodium hydroxide to generate sugammadex sodium.
Chemical Properties	White to Light yellow powder to crystal.Soluble in water, insoluble in methanol and ethanol.
Originator	Organon (Netherlands)
Uses	Sugammadex Sodium is the first in a class of drugs called selective relaxant binding agents that offers improved termination of the paralytic effects of neuromuscular blocking agents and may have many potential peri-operative benefits.
Application	Sugammadex sodium is a modified γ-cyclodextrin. It is a selective relaxant binding agent (SRBA) indicated for reversal of neuromuscular block induced by steroid-based muscle relaxants, such as rocuronium bromide and vecuronium bromide. Sugammadex soium forms a complex with the muscle relaxants, and it reduces the amount of them available to bind to nicotinic cholinergic receptors in the neuromuscular junction.
Definition	ChEBI: Sugammadex sodium is an organic sodium salt that is the octasodium salt of sugammadex. Used for reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults undergoing surgery. It has a role as a neuromuscular agent. It contains a sugammadex(8-).
Brand name	Bridion
Side effects	The most common adverse effects included coughing, movement, vomiting, dry mouth, dysgeusia, hypotension, parosmia, and a sensation of changed temperature.Sugammadex is recommended for the reversal of neuromuscular blockade induced by rocuronium or vecuronium; it should not be used with other steroidal blocking agents since safety and efficacy data are not available for these situations. It should also not be partnered with non-steroidal neuromuscular blockers such as succinylcholine or benzylisoquinolinium-based drugs. Since sugammadex is predominantly cleared by the kidneys, care should be taken when administering this reversal agent in patients with renal impairment.
Mode of action	Sugammadex Sodium is the sodium salt form of sugammadex, a biologically inert, selective relaxant binding agent (SRBA) composed of a modified, anionic gamma cyclodextrin derivative containing a hydrophilic exterior and a hydrophobic core, with neuromuscular blocking drug (NMBD) reversal activity. Upon administration, the negatively charged carboxyl-thio-ether groups of sugammadex selectively and reversibly bind to the positively charged quaternary nitrogen of a steroidal NMBD, such as rocuronium and vecuronium, which was administered at an earlier time for anesthetic purposes. The encapsulation of the NMBD by sugammadex blocks its ability to bind to nicotinic receptors in the neuromuscular junction and thereby reverses the NMBD-induced neuromuscular blockade.

Company Profile Introduction

Recommended supplier

Send Inquriy

Sugammadex sodium

Company Profile Introduction

You may like

Recommended supplier